Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
1716
-
Total 13F shares, excl. options
-
1.1B
-
Shares change
-
+89.6M
-
Total reported value, excl. options
-
$71.4B
-
Value change
-
+$5.87B
-
Put/Call ratio
-
0.8
-
Number of buys
-
739
-
Number of sells
-
-802
-
Price
-
$65.16
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q1 2017
1,864 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q1 2017.
AbbVie Inc. - Common Stock (ABBV) has 1,716 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.1B shares
of 1.77B outstanding shares and own 61.98% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (176M shares), VANGUARD GROUP INC (112M shares), BlackRock Inc. (92.2M shares), STATE STREET CORP (73M shares), NORTHERN TRUST CORP (21.3M shares), BANK OF AMERICA CORP /DE/ (18.9M shares), Bank of New York Mellon Corp (18.1M shares), MORGAN STANLEY (17.2M shares), FEDERATED INVESTORS INC /PA/ (15.5M shares), and STATE FARM MUTUAL AUTOMOBILE INSURANCE CO (15.1M shares).
This table shows the top 1716 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.